Patent · US Active

HLA-G isoform for use in the treatment of a disease associated with bone resorption

US9375464B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 23, 2011
Grant dateJun 28, 2016
Priority date—
Expiry dateApr 15, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P19/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel use of HLA-G isoforms in the treatment or prevention of diseases in which bone resorption is observed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.